Improving survival in pancreatic cancer

Nagoya University researchers and colleagues in Japan have uncovered a molecular pathway that enhances chemotherapy resistance in some pancreatic cancer patients. Targeting an RNA to interrupt its activity could improve patient response to therapy and increase their overall survival.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *